Prevalence of migraine in patients with fibromyalgia




Migraine, Fibromyalgia, Depression, Midas, ID migraine


To evaluate the prevalence of migraine in patients with fibromyalgia and the impacts of these comorbidities on the daily life of patients.
Questionnaires were applied to fibromyalgia patients. The questionnaires were applied through a Google forms application link and in person, printed. We used FIQ, PHQ-9, and ID migraine. And for patients with a positive ID migraine, we applied the Midas subsequently.
Seventy fibromyalgia patients were recruited, age of 47.31 ± 14.5 years. Sixty-five (92.86%) were female and 5 (7.14%) were male. We obtained a prevalence of 60% (n = 42) of migraine associated with fibromyalgia. Among the analyzed variables, severity of depression (p = 0.007), aggregate severity of depression (p = 0.004), and impact of fibromyalgia (p = 0.008) were significantly associated. Among the migraine patients, the vast majority, 34/42 (80.95%), were classified as having severe disability.
There is a high prevalence of migraine in patients with fibromyalgia that has an associated impact on patients' lives, which makes clinical and psychosocial management of these patients necessary.


Download data is not yet available.


DeSantana JM, Perissinotti DMN, Oliveira Junior JO, Correia LMF, Oliveira CM and Fonseca PRB. Definition of pain revised after four decades. Brazilian Journal Of Pain 2020;3(3):197-8 Doi: 10.5935/2595-0118.20200191 DOI:

Silva ALE, Smaidi K, Pires MHR and Pires OC. Prevalence of chronic pain and associated factors among medical students. Revista Dor 2017;18(2):108-111 Doi: 10.5935/1806-0013.20170022 DOI:

Vasconcelos FH and Araújo GC. Prevalence of chronic pain in Brazil: a descriptive study. Brazilian Journal Of Pain 2018;1(2): 176-179 Doi:10.5935/2595-0118.20180034 DOI:

Provenza JR PD, Martinez JE, Paiva ES , Helfenstein M , Heymann R , Matos JMC, Souza EJR. Fibromialgia. Bras Reumatol 2004;44:443-449 DOI:

Medicina FDE. Fibromialgia Introdução Etiologia e Fisiopatologia Quadro clínico. Estudo URDE 2020

Heymann RE, Paiva ES, Martinez JE, Helfenstein M, Rezende MC, Provenza JR, . . . Souza EJR. New guidelines for the diagnosis of fibromyalgia. Revista Brasileira de Reumatologia (English Edition) 2017;57:467-476 Doi: 10.1016/j.rbre.2017.07.002 DOI:

Heymann RE, Paiva ES, Helfenstein Junior M, Pollak DF, Martinez JE, Provenza JR, . . . Fonseca MCM. Consenso brasileiro do tratamento da fibromialgia. Revista Brasileira de Reumatologia 2010;50(1):56-66 Doi: 10.1590/s0482-50042010000100006 DOI:

Sousa Neto AR, Carvalho ARB, Oliveira EMN, Magalhães RLB, Moura MEB and Freitas DRJ. Symptomatic manifestations of the disease caused by coronavirus (COVID-19) in adults: systematic review. Revista Gaúcha de Enfermagem 2021;42(spe):Doi: 10.1590/1983-1447.2021.20200205 DOI:

Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia 2018;38(1):1-211 Doi: 10.1177/0333102417738202 DOI:

Malvieira LC. Migrânea ou Enxaqueca [Monografia]. Uberaba, Minas Gerais: Universidade Federal de Minas Gerais; 2011.

Vij B, Whipple MO, Tepper SJ, Mohabbat AB, Stillman M and Vincent A. Frequency of Migraine Headaches in Patients With Fibromyalgia. Headache: The Journal of Head and Face Pain 2015;55(6):860-865 Doi: 10.1111/head.12590 DOI:

Liu H-Y, Fuh J-L, Lin Y-Y, Chen W-T and Wang S-J. Suicide risk in patients with migraine and comorbid fibromyalgia. Neurology 2015;85(12):1017-1023 Doi: 10.1212/wnl.0000000000001943 DOI:

Mattos ACMT, Souza JA, Moreira Filho PF, Jurno ME and Velarde LGC. ID-Migraine™ questionnaire and accurate diagnosis of migraine. Arquivos de Neuro-Psiquiatria 2017;75(7):446-450 Doi: 10.1590/0004-282x20170069 DOI:

Marques AP, Santos AMB, Assumpção A, Matsutani LA, Lage LV and Pereira CAB. Validação da versão brasileira do Fibromyalgia Impact Questionnaire (FIQ). Revista Brasileira de Reumatologia 2006;46(1):24-31 Doi: 10.1590/s0482-50042006000100006 DOI:

Pharmaceuticals A. The Migraine Disability Assessment Test: Innovative Medical Research; 2007 [updated; cited. Available from:]

Santos IS, Tavares BF, Munhoz TN, Almeida LSP, Silva NTB, Tams BD, . . . Matijasevich A. Sensibilidade e especificidade do Patient Health Questionnaire-9 (PHQ-9) entre adultos da população geral. Cadernos de Saúde Pública 2013;29(8):1533-1543 Doi: 10.1590/s0102-311x2013001200006 DOI:

Patient health questionnaire (PHQ-9)[Internet]. Stanford University. 2005 [cited. Available from:]

Sommer C, Wolfe F, Walitt B, Perrot S, Rasker JJ and Häuser W. Fibromyalgia diagnosis and biased assessment: Sex, prevalence and bias. Plos One 2018;13(9):e0203755 Doi: 10.1371/journal.pone.0203755 DOI:

Di Carlo M, Farah S, Bazzichi L, Atzeni F, Govoni M, Biasi G, . . . Salaffi F. Fibromyalgia severity according to age categories: results of a cross-sectional study from a large national database. Clinical and Experimental Rheumatology 2021;40(6):1084-1090 Doi: 10.55563/clinexprheumatol/od40pa DOI:

Abeles AM, Pillinger MH, Solitar BM and Abeles M. Narrative Review: The Pathophysiology of Fibromyalgia. Annals of Internal Medicine 2007;146(10):726-34 Doi: 10.7326/0003-4819-146-10-200705150-00006 DOI:

Clauw DJ. Fibromyalgia and Related Conditions. Mayo Clinic Proceedings 2015;90(5):680-692 Doi: 10.1016/j.mayocp.2015.03.014 DOI:

Caldarella MP, Giamberardino MA, Sacco F, Affaitati G, Milano A, Lerza R, . . . Neri M. Sensitivity Disturbances in Patients with Irritable Bowel Syndrome and Fibromyalgia. The American Journal of Gastroenterology 2006;101(12):2782-2789 Doi: 10.1111/j.1572-0241.2006.00823.x DOI:

Affaitati G, Costantini R, Fabrizio A, Lapenna D, Tafuri E and Giamberardino MA. Effects of treatment of peripheral pain generators in fibromyalgia patients. European Journal of Pain 2011;15(1):61-69 Doi: 10.1016/j.ejpain.2010.09.002 DOI:

Vecchiet L, Giamberardino M, Bigontina P and Dragani L Comparative sensory evaluation of parietal tissues in painful and non-painful areas in fibromyalgia and myofascial pain syndrome. In: Gebhart GF, Hammond DL, Jensen TS. Proceedings of the 7th World Congress on Pain. 2 2 ed. Seattle: IASP Press, 1994. p. 1184.

Pinheiro RC, Uchida RR, Mathias LAST, Perez MV and Cordeiro Q. Prevalência de sintomas depressivos e ansiosos em pacientes com dor crônica. Jornal Brasileiro de Psiquiatria 2014;63(3):213-219 Doi: 10.1590/0047-2085000000028 DOI:

Bair MJ, Robinson RL, Katon W and Kroenke K. Depression and Pain Comorbidity. Archives of Internal Medicine 2003;163(20):2433 Doi: 10.1001/archinte.163.20.2433 DOI:

IsHak WW, Wen RY, Naghdechi L, Vanle B, Dang J, Knosp M, . . . Louy C. Pain and Depression: A Systematic Review. Harvard Review of Psychiatry 2018;26(6):352-363 Doi: 10.1097/hrp.0000000000000198 DOI:

Frediani F and Villani V. Migraine and depression. Neurological Sciences 2007;28(S2):S161-S165 Doi: 10.1007/s10072-007-0771-7 DOI:

Albuquerque A, Albuquerque L and Moreira-Filho P. Ansiedade e Depressão em Pacientes Migranosos. Revista Neurociências 2013;21(22-27 ) Doi: 10.4181/RNC.2013.21.689.6p DOI:

Queiroz LP. Worldwide Epidemiology of Fibromyalgia. Current Pain and Headache Reports 2013;17(8):356 Doi: 10.1007/s11916-013-0356-5 DOI:




How to Cite

Vieira LDMM, Florisbelo AMC, Ribeiro AF, De Carvalho BS, Campos IML, Magri PDN, de Paula FAC, Jurno M. Prevalence of migraine in patients with fibromyalgia. Headache Med [Internet]. 2023 Sep. 14 [cited 2024 May 23];14(2):97-103. Available from:




Similar Articles

You may also start an advanced similarity search for this article.

Most read articles by the same author(s)